These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23436263)

  • 1. Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance.
    Lombardo F; Waters NJ; Argikar UA; Dennehy MK; Zhan J; Gunduz M; Harriman SP; Berellini G; Liric Rajlic I; Obach RS
    J Clin Pharmacol; 2013 Feb; 53(2):178-91. PubMed ID: 23436263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: volume of distribution at steady state.
    Lombardo F; Waters NJ; Argikar UA; Dennehy MK; Zhan J; Gunduz M; Harriman SP; Berellini G; Rajlic IL; Obach RS
    J Clin Pharmacol; 2013 Feb; 53(2):167-77. PubMed ID: 23436262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.
    Ward KW; Smith BR
    Drug Metab Dispos; 2004 Jun; 32(6):603-11. PubMed ID: 15155551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
    Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
    J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies prediction of human drug clearance based on scaling data from one or two animal species.
    Tang H; Hussain A; Leal M; Mayersohn M; Fluhler E
    Drug Metab Dispos; 2007 Oct; 35(10):1886-93. PubMed ID: 17646280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.
    Evans CA; Jolivette LJ; Nagilla R; Ward KW
    Drug Metab Dispos; 2006 Jul; 34(7):1255-65. PubMed ID: 16621936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR.
    Morris ME; Yang X; Gandhi YA; Bhansali SG; Benincosa LJ
    Biopharm Drug Dispos; 2012 Jan; 33(1):1-14. PubMed ID: 22170504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in distribution and prediction of human V(ss) from preclinical data.
    Berry LM; Li C; Zhao Z
    Drug Metab Dispos; 2011 Nov; 39(11):2103-16. PubMed ID: 21852367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time.
    Ward KW; Smith BR
    Drug Metab Dispos; 2004 Jun; 32(6):612-9. PubMed ID: 15155552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption.
    Paine SW; Ménochet K; Denton R; McGinnity DF; Riley RJ
    Drug Metab Dispos; 2011 Jun; 39(6):1008-13. PubMed ID: 21357702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of human drug clearance using multiexponential techniques.
    Goteti K; Brassil PJ; Good SS; Garner CE
    J Clin Pharmacol; 2008 Oct; 48(10):1226-36. PubMed ID: 18559487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of human drug clearance from two species: a comparison of several allometric methods.
    Goteti K; Garner CE; Mahmood I
    J Pharm Sci; 2010 Mar; 99(3):1601-13. PubMed ID: 19827101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.
    Obach RS; Baxter JG; Liston TE; Silber BM; Jones BC; MacIntyre F; Rance DJ; Wastall P
    J Pharmacol Exp Ther; 1997 Oct; 283(1):46-58. PubMed ID: 9336307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of US Food and Drug Administration and pharmacologically guided approaches to determine the maximum recommended starting dose for first-in-human clinical trials in adult healthy men.
    Imam MT; Venkateshan SP; Tandon M; Saha N; Pillai KK
    J Clin Pharmacol; 2011 Dec; 51(12):1655-64. PubMed ID: 21415286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.